Les marqueurs du liquide céphalo-rachidien pour le diagnostic des maladies à prions

Pratique Neurologique - FMC - Tập 9 - Trang 186-191 - 2018
J.P. Brandel1, K. Grznarova1, A. Culeux1, E. Levavasseur1, L. Peckeu1, A. Welaratne1, J.L. Laplanche1, S. Haik1
1Pôle des maladies du système nerveux, service de neuropathologie, cellule nationale Creutzfeldt-Jakob, groupe hospitalier La Pitié-Salpêtrière-Charles Foix, hôpital Pitié-Salpêtrière, CHU de Paris, 47–83, boulevard de l’Hôpital, 75013 Paris, France

Tài liệu tham khảo

Prusiner, 1998, Prions, Proc Natl Acad Sci U S A, 95, 13363, 10.1073/pnas.95.23.13363 Hsich, 1996, The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies, N Engl J Med, 335, 924, 10.1056/NEJM199609263351303 Peoc’h, 2001, Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt–Jakob patients by a highly sensitive capture assay, Neurosci Lett, 301, 167, 10.1016/S0304-3940(01)01619-6 Zerr, 1998, Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt–Jakob disease, Ann Neurol, 43, 32, 10.1002/ana.410430109 Beaudry, 1999, 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease, Dement Geriatr Cogn Disord, 10, 40, 10.1159/000017095 Brandel, 2000, Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates, Neurology, 54, 1095, 10.1212/WNL.54.5.1095 Collins, 2000, Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid, J Clin Neurosci, 7, 203, 10.1054/jocn.1999.0193 Kenney, 2000, An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt–Jakob disease patients, Ann Neurol, 48, 395, 10.1002/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A Zerr, 2000, Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease, Neurology, 55, 811, 10.1212/WNL.55.6.811 Muayqil, 2012, Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology, Neurology, 79, 1499, 10.1212/WNL.0b013e31826d5fc3 Peckeu, 2017, Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt–Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009, Euro Surveill, 22, 10.2807/1560-7917.ES.2017.22.41.16-00715 Brandel, 2001, 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt–Jakob disease patients, Ann Neurol, 49, 257, 10.1002/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO;2-X Kovács, 2005, EUROCJD. Genetic prion disease: the EUROCJD experience, Hum Genet, 118, 166, 10.1007/s00439-005-0020-1 Green, 2001, Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt–Jakob disease, J Neurol Neurosurg Psychiatry, 70, 744, 10.1136/jnnp.70.6.744 Brandel, 2009, Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain, Ann Neurol, 65, 249, 10.1002/ana.21583 Chohan, 2010, The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review, J Neurol Neurosurg Psychiatry, 81, 1243, 10.1136/jnnp.2009.197962 Coulthart, 2011, Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt–Jakob disease in Canada: a 6-year prospective study, BMC Neurol, 11, 133, 10.1186/1471-2377-11-133 Atarashi, 2011, Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion, Nat Med, 17, 175, 10.1038/nm.2294 McGuire, 2012, Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease, Ann Neurol, 72, 278, 10.1002/ana.23589 Cramm, 2016, Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt–Jakob disease, Mol Neurobiol, 53, 1896, 10.1007/s12035-015-9133-2 Park, 2016, Real-Time quaking-induced conversion analysis for the diagnosis of sporadic Creutzfeldt–Jakob disease in Korea, J Clin Neurol, 12, 101, 10.3988/jcn.2016.12.1.101 Groveman, 2016, Extended and direct evaluation of RT-QuIC assays for Creutzfeldt–Jakob disease diagnosis, Ann Clin Transl Neurol, 4, 139, 10.1002/acn3.378 McGuire, 2016, Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: an international study, Ann Neurol, 80, 160, 10.1002/ana.24679 Foutz, 2017, Diagnostic and prognostic value of human prion detection in cerebrospinal fluid, Ann Neurol, 81, 79, 10.1002/ana.24833 Mantokoudis, 2015, An unusual stroke-like clinical presentation of Creutzfeldt–Jakob disease: acute vestibular syndrome, Neurologist, 19, 96, 10.1097/NRL.0000000000000019 Zéphir, 2009, Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt–Jakob disease, J Neurol, 256, 134, 10.1007/s00415-009-0037-9 Lapergue, 2010, Creutzfeldt–Jakob disease mimicking nonconvulsive status epilepticus, Neurology, 74, 1995, 10.1212/WNL.0b013e3181e39703